Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Isotretinoin in Mild to Moderate Alzheimer's Disease
NCT01560585Phase 2Terminated
- Sponsor
- University Hospitals Cleveland Medical Center
- Start
- Apr 2012
- Primary completion
- Aug 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of isotretinoin in Alzheimer's disease (AD), sponsored by University Hospitals Cleveland Medical Center. Started Apr 2012; status: terminated.
02
Drugs
isotretinoin
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT01560585.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01560585.